Healthcare -
Biotechnology - NASDAQ - US
$ 6.16
-0.324 %
$ 276 M
Market Cap
-11.41
P/E
YMAB - OPERATING INCOME
Operating Income YMAB - Y-mAbs Therapeutics, Inc.
-25.7 M
LAST VALUE
52.84%
2 YEAR CAGR
9.90%
5 YEAR CAGR
0.00%
10 YEAR CAGR